Filing Details
- Accession Number:
- 0001567619-22-016462
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-18 17:50:01
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-08-18 17:50:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623715 | Imago Biosciences Inc. | IMGO | Pharmaceutical Preparations (2834) | 454915810 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861067 | G. Laura Eichorn | C/O Imago Biosciences, Inc. 329 Oyster Point Blvd, 3Rd Floor South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-16 | 533 | $2.52 | 208,270 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-16 | 533 | $19.50 | 207,737 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-17 | 373 | $2.52 | 208,110 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-17 | 373 | $19.50 | 207,737 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-16 | 533 | $0.00 | 533 | $2.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-17 | 373 | $0.00 | 373 | $2.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,423 | 2021-01-01 | 2027-03-28 | No | 4 | M | Direct |
| 100,050 | 2021-01-01 | 2027-03-28 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- The transaction was executed in multiple trades in prices ranging from $19.50 to $19.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
